Cambridge, MA, United States of America

Sanjay Shivayogi Magavi

USPTO Granted Patents = 6 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Sanjay Shivayogi Magavi

Introduction

Sanjay Shivayogi Magavi is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of demyelinating diseases. With a total of six patents to his name, Magavi's work is recognized for its potential impact on neurodegenerative conditions.

Latest Patents

One of his latest patents focuses on triazole compounds that are useful as modulators of demyelinating diseases. The invention relates to triazole compounds of formula I and I' or pharmaceutically acceptable salts thereof. These compounds are designed to be effective in treating various demyelinating and neurodegenerative diseases, including multiple sclerosis. Additionally, the invention provides pharmaceutically acceptable compositions comprising these compounds, methods of using the compositions, and kits for treatment.

Career Highlights

Sanjay Shivayogi Magavi is currently associated with Vertex Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

Magavi has collaborated with notable colleagues, including Michael Paul Emery and James Edward Sinclair. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Sanjay Shivayogi Magavi's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a key inventor in the treatment of demyelinating diseases. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…